✦ LIBER ✦

A single-blind cross over study investigating the efficacy of standard and controlled release levodopa in combination with entacapone in the treatment of end-of-dose effect in people with Parkinson’s disease

✍ Scribed by R. Iansek; M. Danoudis

Book ID: 116820977
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 130 KB
Volume: 17
Category: Article
ISSN: 1353-8020
DOI: 10.1016/j.parkreldis.2011.04.012

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The effect of levodopa dose and body wei

The effect of levodopa dose and body weight on dyskinesia in a prevalent population of people with Parkinson’s disease

✍ Richard W. Walker; Anna R. Howells; William K. Gray 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 111 KB

Efficacy and tolerability of entacapone

Efficacy and tolerability of entacapone in patients with Parkinson's disease treated with levodopa plus a dopamine agonist and experiencing wearing-off motor fluctuations. A randomized, double-blind, multicentre study

✍ G. Fénelon; S. Giménez-Roldán; J. L. Montastruc; F. Bermejo; F. Durif; I. Bourde 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 121 KB

Double-blind, single-dose, cross-over st

Double-blind, single-dose, cross-over study of the effects of pramipexole, pergolide, and placebo on rest tremor and UPDRS part III in Parkinson's disease

✍ Prithiva Navan; Leslie J. Findley; Jim A. R. Jeffs; Ronald K. B. Pearce; Peter G 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB 👁 1 views

## Abstract Tremor is one of the cardinal signs of Parkinson's disease (PD) but its response to antiparkinsonian medication is variable. It has been postulated that pramipexole may have a stronger antiparkinsonian tremor effect than pergolide, another direct acting dopamine agonist medication, poss

A six-month multicentre, double-blind, b

A six-month multicentre, double-blind, bromocriptine-controlled study of the safety and efficacy of ropinirole in the treatment of patients with Parkinson's disease not optimally controlled byl-dopa

✍ E. R. Brunt; D. J. Brooks; A. D. Korczyn; J.-L. Montastruc; F. Stocchi; on behal 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 79 KB

Combining entacapone with levodopa/DDCI

Combining entacapone with levodopa/DDCI improves clinical status and quality of life in Parkinson’s Disease (PD) patients experiencing wearing-off, regardless of the dosing frequency: results of a large multicentre open-label study

✍ M. Onofrj; A. Thomas; F. Vingerhoets; W. Martin; S. Giménez-Roldán; J.-P. Azulay 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 292 KB

Clinical and endosonographic effect of c

Clinical and endosonographic effect of ciprofloxacin on the treatment of perianal fistulae in Crohn's disease with infliximab: a double-blind placebo-controlled study

✍ R. L. West; C. J. van der Woude; B. E. Hansen; R. J. F. Felt-Bersma; A. J. P. va 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB